Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules

The Malaria Box collection includes 400 chemically diverse small molecules with documented potency against malaria parasite growth, but the underlying modes of action are largely unknown. Using complementary phenotypic screens against Plasmodium falciparum and Toxoplasma gondii, we report phenotype-...

Full description

Bibliographic Details
Main Authors: Preiser, Peter Rainer, Reddy, D. Srinivasa, Tan, Kevin S. W., Shanmugam, Dhanasekaran, Chandramohanadas, Rajesh, Subramanian, Gowtham, Belekar, Meenakshi A., Shukla, Anurag, Tong, Jie Xin, Sinha, Ameya, Chu, Trang T. T., Kulkarni, Akshay S.
Other Authors: Sullivan, William J.
Format: Journal Article
Language:English
Published: 2019
Subjects:
Online Access:https://hdl.handle.net/10356/88939
http://hdl.handle.net/10220/48346
_version_ 1811694138956972032
author Preiser, Peter Rainer
Reddy, D. Srinivasa
Tan, Kevin S. W.
Shanmugam, Dhanasekaran
Chandramohanadas, Rajesh
Subramanian, Gowtham
Belekar, Meenakshi A.
Shukla, Anurag
Tong, Jie Xin
Sinha, Ameya
Chu, Trang T. T.
Kulkarni, Akshay S.
author2 Sullivan, William J.
author_facet Sullivan, William J.
Preiser, Peter Rainer
Reddy, D. Srinivasa
Tan, Kevin S. W.
Shanmugam, Dhanasekaran
Chandramohanadas, Rajesh
Subramanian, Gowtham
Belekar, Meenakshi A.
Shukla, Anurag
Tong, Jie Xin
Sinha, Ameya
Chu, Trang T. T.
Kulkarni, Akshay S.
author_sort Preiser, Peter Rainer
collection NTU
description The Malaria Box collection includes 400 chemically diverse small molecules with documented potency against malaria parasite growth, but the underlying modes of action are largely unknown. Using complementary phenotypic screens against Plasmodium falciparum and Toxoplasma gondii, we report phenotype-specific hits based on inhibition of overall parasite growth, apicoplast segregation, and egress or host invasion, providing hitherto unavailable insights into the possible mechanisms affected. First, the Malaria Box library was screened against tachyzoite stage T. gondii and the half-maximal effective concentrations (EC50s) of molecules showing ≥80% growth inhibition at 10 µM were determined. Comparison of the EC50s for T. gondii and P. falciparum identified a subset of 24 molecules with nanomolar potency against both parasites. Thirty molecules that failed to induce acute growth inhibition in T. gondii tachyzoites in a 2-day assay caused delayed parasite death upon extended exposure, with at least three molecules interfering with apicoplast segregation during daughter cell formation. Using flow cytometry and microscopy-based examinations, we prioritized 26 molecules with the potential to inhibit host cell egress/invasion during asexual developmental stages of P. falciparum. None of the inhibitors affected digestive vacuole integrity, ruling out a mechanism mediated by broadly specific protease inhibitor activity. Interestingly, five of the plasmodial egress inhibitors inhibited ionophore-induced egress of T. gondii tachyzoites. These findings highlight the advantage of comparative and targeted phenotypic screens in related species as a means to identify lead molecules with a conserved mode of action. Further work on target identification and mechanism analysis will facilitate the development of antiparasitic compounds with cross-species efficacy.
first_indexed 2024-10-01T07:02:49Z
format Journal Article
id ntu-10356/88939
institution Nanyang Technological University
language English
last_indexed 2024-10-01T07:02:49Z
publishDate 2019
record_format dspace
spelling ntu-10356/889392023-02-28T17:00:01Z Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules Preiser, Peter Rainer Reddy, D. Srinivasa Tan, Kevin S. W. Shanmugam, Dhanasekaran Chandramohanadas, Rajesh Subramanian, Gowtham Belekar, Meenakshi A. Shukla, Anurag Tong, Jie Xin Sinha, Ameya Chu, Trang T. T. Kulkarni, Akshay S. Sullivan, William J. School of Biological Sciences DRNTU::Science::Biological sciences Malaria MMV Malaria Box The Malaria Box collection includes 400 chemically diverse small molecules with documented potency against malaria parasite growth, but the underlying modes of action are largely unknown. Using complementary phenotypic screens against Plasmodium falciparum and Toxoplasma gondii, we report phenotype-specific hits based on inhibition of overall parasite growth, apicoplast segregation, and egress or host invasion, providing hitherto unavailable insights into the possible mechanisms affected. First, the Malaria Box library was screened against tachyzoite stage T. gondii and the half-maximal effective concentrations (EC50s) of molecules showing ≥80% growth inhibition at 10 µM were determined. Comparison of the EC50s for T. gondii and P. falciparum identified a subset of 24 molecules with nanomolar potency against both parasites. Thirty molecules that failed to induce acute growth inhibition in T. gondii tachyzoites in a 2-day assay caused delayed parasite death upon extended exposure, with at least three molecules interfering with apicoplast segregation during daughter cell formation. Using flow cytometry and microscopy-based examinations, we prioritized 26 molecules with the potential to inhibit host cell egress/invasion during asexual developmental stages of P. falciparum. None of the inhibitors affected digestive vacuole integrity, ruling out a mechanism mediated by broadly specific protease inhibitor activity. Interestingly, five of the plasmodial egress inhibitors inhibited ionophore-induced egress of T. gondii tachyzoites. These findings highlight the advantage of comparative and targeted phenotypic screens in related species as a means to identify lead molecules with a conserved mode of action. Further work on target identification and mechanism analysis will facilitate the development of antiparasitic compounds with cross-species efficacy. ASTAR (Agency for Sci., Tech. and Research, S’pore) MOE (Min. of Education, S’pore) Published version 2019-05-23T07:50:51Z 2019-12-06T17:14:10Z 2019-05-23T07:50:51Z 2019-12-06T17:14:10Z 2018 Journal Article Subramanian, G., Belekar, M. A., Shukla, A., Tong, J. X., Sinha, A., Chu, T. T. T., . . . Chandramohanadas, R. (2018). Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules. mSphere, 3(1), e00534-17-. doi:10.1128/mSphere.00534-17 https://hdl.handle.net/10356/88939 http://hdl.handle.net/10220/48346 10.1128/mSphere.00534-17 en mSphere © 2018 Subramanian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. 22 p. application/pdf
spellingShingle DRNTU::Science::Biological sciences
Malaria
MMV Malaria Box
Preiser, Peter Rainer
Reddy, D. Srinivasa
Tan, Kevin S. W.
Shanmugam, Dhanasekaran
Chandramohanadas, Rajesh
Subramanian, Gowtham
Belekar, Meenakshi A.
Shukla, Anurag
Tong, Jie Xin
Sinha, Ameya
Chu, Trang T. T.
Kulkarni, Akshay S.
Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules
title Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules
title_full Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules
title_fullStr Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules
title_full_unstemmed Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules
title_short Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules
title_sort targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules
topic DRNTU::Science::Biological sciences
Malaria
MMV Malaria Box
url https://hdl.handle.net/10356/88939
http://hdl.handle.net/10220/48346
work_keys_str_mv AT preiserpeterrainer targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT reddydsrinivasa targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT tankevinsw targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT shanmugamdhanasekaran targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT chandramohanadasrajesh targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT subramaniangowtham targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT belekarmeenakshia targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT shuklaanurag targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT tongjiexin targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT sinhaameya targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT chutrangtt targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules
AT kulkarniakshays targetedphenotypicscreeninginplasmodiumfalciparumandtoxoplasmagondiirevealsnovelmodesofactionofmedicinesformalariaventuremalariaboxmolecules